Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness

References

• Fava M, Kendler KS. Major depressive disorder. Neuron 2000;28:335–41.
   PubMed Web of Science ®Google Scholar
• American Psychiatric A, Diagnostic and Statistical Manual of Mental Disorders, (4th edn.) (text revision (DSM-IV-TR)). Washington, DC: American Psychiatric Association; 2000.
   Google Scholar
• Hepgul N, Cattaneo A, Zunszain PA, Pariante CM. Depression pathogenesis and treatment: what can we learn from blood mRNA expression? BMC Med 2013;11:1.
   PubMed Web of Science ®Google Scholar
• Veenstra-VanderWeele J, Anderson GM, Cook EH. Pharmacogene-tics and the serotonin system: initial studies and future directions. Eur J Pharmacol 2000;410:165–81.
   PubMed Web of Science ®Google Scholar
• Baganz NL, Blakely RD. A dialogue between the immune system and brain, spoken in the language of serotonin. ACS Chem Neurosci 2012;4:48–63.
   PubMed Web of Science ®Google Scholar
• Fajardo O, Galeno J, Urbina M, Carreira I, Lima L. Serotonin, serotonin 5-HT 1A receptors and dopamine in blood peripheral lymphocytes of major depression patients. Int Immunopharmacol 2003;3:1345–52.
   PubMed Web of Science ®Google Scholar
• Meneses A. 5-HT system and cognition. Neurosci Biobehav Rev 1999;23:1111–25.
   PubMed Web of Science ®Google Scholar
• De Berardis D, Conti CM, Serroni N, Moschetta FS, Olivieri L, Carano A, et al. The effect of newer serotonin-noradrenalin antidepressants on cytokine production: A review of the current literature. Int J Immunopathol Pharmacol 2010;23:417–22.
   PubMed Web of Science ®Google Scholar
• Kim YK, Na KS, Myint AM, Leonard BE. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2016;64:277–84.
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009;65:732–41.
   PubMed Web of Science ®Google Scholar
• Na KS, Lee KJ, Lee JS, Cho YS, Jung HY. Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:79–85.
   PubMed Web of Science ®Google Scholar
• Shajib MS, Khan WI. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiol (Oxf) 2015;213:561–74.
   PubMed Web of Science ®Google Scholar
• Hannon J, Hoyer D. Molecular biology of 5-HT receptors. Behav Brain Res 2008;195:198–213.
   PubMed Web of Science ®Google Scholar
• Barnes NM, Neumaier JF. Neuronal 5-HT receptors and SERT. Tocris Biosci Sci Rev Ser 2011;34:1–6.
   Google Scholar
• Bhagwagar Z, Hinz R, Taylor M, Fancy S, Cowen P, Grasby P. Increased 5-HT 2A receptor binding in euthymic, medication-free patients recovered from depression: A positron emission study with [11 C] MDL 100,907. Am J Psychiatry 2006;163:1580–7.
   PubMed Web of Science ®Google Scholar
• Peroutka SJ, Snyder SH. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science (80-) 1980;210:88–90.
   PubMed Web of Science ®Google Scholar
• Marek GJ, Carpenter LL, McDougle CJ, Price LH. Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology 2003;28:402–12.
   PubMed Web of Science ®Google Scholar
• Bétry C, Etiévant A, Oosterhof C, Ebert B, Sanchez C, Haddjeri N. Role of 5-HT3 receptors in the antidepressant response. Pharmaceuticals (Basel) 2011;4:603–29.
   Google Scholar
• Gatt JM, Williams LM, Schofield PR, Dobson‐Stone C, Paul RH, Grieve SM, et al. Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress Anxiety 2010;27:752–9.
   PubMed Web of Science ®Google Scholar
• Gatt JM, Nemeroff CB, Schofield PR, Paul RH, Clark CR, Gordon E, et al. Early life stress combined with serotonin 3A receptor and brain-derived neurotrophic factor valine 66 to methionine genotypes impacts emotional brain and arousal correlates of risk for depression. Biol Psychiatry 2010;68:818–24.
   PubMed Web of Science ®Google Scholar
• Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006;147:126–32.
   PubMed Web of Science ®Google Scholar
• Sullivan PF, Fan C, Perou CM. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet B Neuropsychiatr Genet 2006;141:261–8.
   Web of Science ®Google Scholar
• Shooshtari MH, Davari-Ashtiani R, Shahrivar Z, Shabani A, Semnani Y, Kaviani H, et al. Structured clinical interview for DSM-IV (SCID Persian translation and cultural adaptation). Iran J Psychiatry 2007;2:46–8.
   Google Scholar
• Hamilton MA. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278–96.
   PubMed Web of Science ®Google Scholar
• Beck AT. A systematic investigation of depression. Compr Psychiatry 1961;2:163–70.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001;25:402–8.
   PubMed Web of Science ®Google Scholar
• Knorr U, Koefoed P, Gluud C, Wetterslev J, Winkel P, Gether U, et al. Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - A secondary outcome analysis from the randomized AGENDA trial. Nord J Psychiatry 2016;70:297–302.
   PubMed Web of Science ®Google Scholar
• Willner P, Scheel-Krüger J, Belzung C. The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev 2013;37:2331–71.
   PubMed Web of Science ®Google Scholar
• Rivera-Baltanas T, Olivares JM, Martinez-Villamarin JR, Fenton EY, Kalynchuk LE, Caruncho HJ. Serotonin 2A receptor clustering in peripheral lymphocytes is altered in major depression and may be a biomarker of therapeutic efficacy. J Affect Disord 2014;163:47–55.
   PubMed Web of Science ®Google Scholar
• Khait VD, Huang YY, Malone KM, Oquendo M, Brodsky B, Sher L, et al. Is there circannual variation of human platelet 5-HT(2A) binding in depression? J Affect Disord 2002;71:249–58.
   PubMed Web of Science ®Google Scholar
• Pandey GN, Pandey SC, Janicak PG, Marks RC, Davis JM. Platelet serotonin-2 receptor binding sites in depression and suicide. Biol Psychiatry 1990;28:215–22.
   PubMed Web of Science ®Google Scholar
• Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, et al. Autoradiographic demonstration of increased serotonin 5-HT2 and β-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 1990;47:1038. 47.
   PubMed Web of Science ®Google Scholar
• Hrdina PD, Demeter E, Vu TB, Sótónyi P, Palkovits M. 5-HT uptake sites and 5-HT 2 receptors in brain of antidepressant-free suicide victims/depressives: Increase in 5-HT 2 sites in cortex and amygdala. Brain Res 1993;614:37–44.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Maeso J, Rodriguez-Puertas R, Meana JJ, Garcia-Sevilla JA, Guimon J. Neurotransmitter receptor-mediated activation of G-proteins in brains of suicide victims with mood disorders: Selective supersensitivity of alpha∼ 2∼ A-adrenoceptors. Mol Psychiatry 2002;7:755–67.
   PubMed Web of Science ®Google Scholar
• Stockmeier CA. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J Psychiatr Res 2003;37:357–73.
   PubMed Web of Science ®Google Scholar
• Martins LC, Rocha NP, Torres KC, dos Santos RR, França GS, de Moraes EN, et al. Disease-specific expression of the serotonin-receptor 5-HT2C in natural killer cells in Alzheimer's dementia. J Neuroimmunol 2012;251:73–9.
   PubMed Web of Science ®Google Scholar
• Chapter in book 30. Duman RS, The neurochemistry of depressive disorders: Preclinical studies. In: Charney DS, Nestler EJ, editors. Neurobiology of Mental Illness, (2nd edn). New York: Oxford University Press; 2005:421.
   Google Scholar
• Meyer JH, McMain S, Kennedy SH, Korman L, Brown GM, DaSilva JN, et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry 2003;160:90–9.
   PubMed Web of Science ®Google Scholar
• Urbina M, Pineda S, Piñango L, Carreira I, Lima L. [3 H] Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int J Immunopharmacol 1999;21:631–46.
   PubMed Web of Science ®Google Scholar
• Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT1A and 5-HT2A receptors in depression. J Psychiatry Neurosci 2004;29:252.
   PubMed Web of Science ®Google Scholar
• Hejazi SH, Ahangari G, Pornour M, Deezagi A, Aminzadeh S, Ahmadkhaniha HR, et al. Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pac J Cancer Prev 2013;15:4455–8.
   Google Scholar
• Shariati GR, Ahangari G, Hossein-nezhad A, Asadi SM, Pooyafard F, Ahmadkhaniha HR. Expression changes of serotonin receptor gene subtype 5HT3a in peripheral blood mononuclear cells from schizophrenic patients treated with haloperidol and Olanzapin. Iran J Allergy Asthma Immunol 2009;8:135–9.
   PubMed Web of Science ®Google Scholar
• Ahern GP. 5-HT and the immune system. Curr Opin Pharmacol 2011;11:29–33.
   PubMed Web of Science ®Google Scholar